North America Clinical Trial Management Market Forecast 2021-2028

Inkwood Research
154 Pages - INKWOOOD10089
$1,250.00

KEY FINDINGS
The North America clinical trial management market growth is anticipated to progress at a CAGR of 11.24% during the forecast period, 2021-2028. The region conducts clinical trials on a large scale. Also, the high awareness of CTM (clinical trial management) benefits and major pharmaceutical companies' presence propel market growth.
MARKET INSIGHTS
The United States and Canada are assessed for the North America clinical trial management market growth evaluation. In Canada, the growing trend of decentralization has enabled the scope of testing, with private players entering the segment. The clinical laboratory of the country receives funding from the Ministry of Health. The public labs, physicians' offices, private labs, and hospital labs generate revenue for diagnostics testing. Also, private labs are set to be integrated with hospital labs for clinical diagnostics. Many tests outsourced from the US are projected to benefit the market growth. The clinical laboratories are impacted by multiple trends, which affect the overall healthcare system. The rising deployment of new technologies like artificial intelligence and test automation has resulted in labs quickly adapting to shifting demographics.
Furthermore, the growing investments in clinical trials are accredited to its world-leading higher education system and the publicly-funded healthcare system. Also, the government is initiating several steps to increase R&D capabilities. Such developments are expected to influence market growth in Canada.
COMPETITIVE INSIGHTS
Some of the major companies in the market include Bioclinica Inc, Parexel International Corporation, Veeva Systems Inc, Mednet Solutions Inc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

'

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. PARENT MARKET ANALYSIS - HEALTHCARE
3.2. MARKET SCOPE
3.3. KEY DRIVERS
3.3.1. OUTSOURCING OF CLINICAL TRIALS
3.3.2. GROWTH IN THE NUMBER OF CLINICAL TRIALS
3.3.3. AWARENESS REGARDING THE BENEFITS OF USING CTM SOFTWARE
3.3.4. INCIDENCES OF CHRONIC DISEASES
3.3.5. RESEARCH & DEVELOPMENT
3.4. KEY RESTRAINTS
3.4.1. SCARCITY OF SKILLED HEALTHCARE PROFESSIONALS
3.4.2. COST OF IMPLEMENTATION
3.4.3. SECURITY CONCERNS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON CLINICAL TRIAL MANAGEMENT MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. THREAT OF SUBSTITUTION
4.3.4. THREAT OF NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
5. MARKET BY END-USER
5.1. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
5.2. CLINICAL RESEARCH ORGANIZATIONS
5.3. HEALTHCARE PROVIDERS
6. MARKET BY PRODUCT TYPE
6.1. ENTERPRISE-BASED CTM
6.2. SITE-BASED CTM
7. MARKET BY DEPLOYMENT MODEL
7.1. WEB-BASED DEPLOYMENT
7.2. ON-PREMISE DEPLOYMENT
7.3. CLOUD-BASED DEPLOYMENT
8. MARKET BY COMPONENT
8.1. SOFTWARE
8.2. HARDWARE
8.3. SERVICES
9. GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1. MARKET SIZE & ESTIMATES
9.1.2. KEY GROWTH ENABLERS
9.1.3. KEY CHALLENGES
9.1.4. KEY PLAYERS
9.1.5. COUNTRY ANALYSIS
9.1.5.1. UNITED STATES
9.1.5.2. CANADA
10. COMPETITIVE LANDSCAPE
10.1. KEY STRATEGIC DEVELOPMENTS
10.1.1. MERGERS & ACQUISITIONS
10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
10.1.3. PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
10.2. COMPANY PROFILES
10.2.1. ADVARRA (FORTE RESEARCH SYSTEMS INC)
10.2.2. ARISGLOBAL LLC
10.2.3. BIOCLINICA INC
10.2.4. BIO-OPTRONICS INC
10.2.5. IBM CORPORATION
10.2.6. MEDIDATA SOLUTIONS INC
10.2.7. MEDNET SOLUTIONS INC
10.2.8. ORACLE CORPORATION
10.2.9. PAREXEL INTERNATIONAL CORPORATION
10.2.10. VEEVA SYSTEMS INC

1. ADVARRA (FORTE RESEARCH SYSTEMS INC)
2. ARISGLOBAL LLC
3. BIOCLINICA INC
4. BIO-OPTRONICS INC
5. IBM CORPORATION
6. MEDIDATA SOLUTIONS INC
7. MEDNET SOLUTIONS INC
8. ORACLE CORPORATION
9. PAREXEL INTERNATIONAL CORPORATION
10. VEEVA SYSTEMS INC

$1,250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838